seelos therapeutics

NASDAQ:SEEL

Chart

Detailed Quote

Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System ("CNS") disorders and other rare disorders.

Psychedelics Stocks to Watch

Press Releases

May 16, 2024

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 04, 2019

Seelos Therapeutics Gets Notice of Allowance for Another US Patent for SLS-005

Nov 27, 2019

Seelos Therapeutics Begins Dosing in Phase 1 PK/KD Study

See More Press Releases

The Conversation (0)

Alert Options

No alert set

INN Article Notification

Instant Daily Weekly

Alert Option

You will be notified when this event occurs. No additional settings needed.